Cigna Getting Out of Individual ACA Market

Why It Matters

Cigna’s withdrawal signals a strategic shift among large insurers away from a volatile individual market, accelerating consolidation and pressuring providers that rely on exchange‑covered patients. The decision underscores the broader financial fallout from the end of enhanced subsidies.

Key Takeaways

• Cigna will exit individual ACA market by end of 2026
• Enrollees fell from 432k to 355k, projected under 300k
• Market shrank 5% to 23.1 million members in 2026
• HCA expects $600‑$900 million earnings hit from exchange decline
• Tenet forecasts 20% drop in exchange patient volume by year‑end

Pulse Analysis

Cigna’s decision to abandon the individual ACA exchange reflects a broader recalibration among health insurers as federal subsidies phase out. The company’s enrollment slipped from 432,000 in Q1 2025 to 355,000 this quarter, and executives project fewer than 300,000 members by the close of 2026. By shedding a business segment that now represents a "small business" within its portfolio, Cigna aims to redirect capital toward higher‑margin lines such as Medicare Advantage and employer‑based plans, where scale and profitability are more predictable.

The ripple effect is already evident in the hospital sector. HCA Healthcare warned of a $150 million EBITDA shortfall in Q1 alone, reinforcing its full‑year outlook of a $600‑$900 million earnings hit as exchange‑covered admissions tumble. Tenet Healthcare and Universal Health Services echo the sentiment, forecasting 20% and 15% declines respectively in exchange patient volumes, translating into multi‑million‑dollar EBITDA losses. These providers are grappling with patients shifting to lower‑benefit bronze plans or delaying care, which compresses reimbursement rates and raises bad‑debt exposure.

For the ACA marketplace, Cigna’s exit—mirroring Aetna’s earlier pull‑back—accelerates a trend toward consolidation among the remaining carriers. With the exchange pool now at 23.1 million members, down 5% year‑over‑year, insurers may double down on ancillary services, value‑based contracts, or partnerships with health systems to sustain revenue. Investors should monitor enrollment trends, subsidy policy developments, and the strategic reallocation of insurer capital, as these factors will shape profitability and competitive dynamics in the post‑subsidy health insurance landscape.